The following was originally published by NAEMT.
May is Stroke Awareness Month. Stroke is the third leading cause of death and a leading cause of disability in our country. Knowing the signs and symptoms is essential to rapid diagnosis and treatment.
Jack suffered a stroke while on a family fishing trip. Because his brother-in-law recognized the symptoms and immediately called 911, Jack got to the hospital promptly, where he was diagnosed and treated with Activase (alteplase). He noticed an improvement within 2 months, and little by little, was able to return to most of his usual routine. Jack has since married Tessie, the love of his life!
What does Stroke Awareness Month mean to you?
- F.A.S.T. materials — educate your colleagues, patients, friends, and family on the signs, symptoms, and urgency of stroke
- Quality Assessment Tracker — measure your hospital’s assessment and treatment of stroke and compare it to 3 recognized stroke centers of excellence
- Connect with other prominent stroke organizations for additional support and education
Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset of stroke symptoms, and after exclusion of intracranial hemorrhage by a cranial computerized tomography (CT) scan or other diagnostic imaging method sensitive for the presence of hemorrhage (see CONTRAINDICATIONS in the full prescribing information).
All thrombolytic agents increase the risk of bleeding, including intracranial bleeding, and should be used only in appropriate patients. Not all patients with acute ischemic stroke will be eligible for Activase therapy, including patients with evidence of recent or active bleeding; recent (within 3 months) intracranial or intraspinal surgery, serious head trauma, or previous stroke; uncontrolled high blood pressure; or impaired blood clotting.